Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Promote Peritoneal Healing by Activating MAPK-ERK1/2 and PI3K-Akt to Alleviate Postoperative Abdominal Adhesion

<div>Characterization of ADSC and RPCM. (a) Flow cytometry for detection of ADSC surface markers, including CD90, CD105, CD34, and CD45. (b) Morphology of ADSC. (c) Osteogenic. (d) Adipogenic. (e) Chondrogenesis differentiation potential of ADSC. (f) The phenotype of rat peritoneal mesothelial cells (RPMCs) in culture. Immunofluorescence staining of RPMC. Mesothelial cells with (g) E-cadherin, (h) vimentin, and (i) cytokeratin-19. Original magnification: ×200.</div>

Stem Cells International

fig1

Figure 1

Figure 1: Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Promote Peritoneal Healing by Activating MAPK-ERK1/2 and PI3K-Akt to Alleviate Postoperative Abdominal Adhesion 

Figure 1 | Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Promote Peritoneal Healing by Activating MAPK-ERK1/2 and PI3K-Akt to Alleviate Postoperative Abdominal Adhesion 